BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22290920)

  • 1. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.
    Ferreira F; Santos S; Nascimento J; Strabelli T; Carmona M
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):300-5. PubMed ID: 22290920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.
    Aalbers M; ter Horst PG; Hospes W; Hijmering ML; Spanjersberg AJ
    Int J Clin Pharm; 2015 Aug; 37(4):592-8. PubMed ID: 25791346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    J Hosp Infect; 2005 Apr; 59(4):299-303. PubMed ID: 15749317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass.
    Knoderer CA; Saft SA; Walker SG; Rodefeld MD; Turrentine MW; Brown JW; Healy DP; Sowinski KM
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):425-30. PubMed ID: 20864357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative vancomycin pharmacokinetics in cardiac surgery with or without cardiopulmonary bypass.
    Cotogni P; Passera R; Barbero C; Gariboldi A; Moscato D; Izzo G; Rinaldi M
    Ann Pharmacother; 2013 Apr; 47(4):455-63. PubMed ID: 23512663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial.
    Wiesner G; Braun SL; Gruber M; Gertler R; Lange R; Tassani P; Martin K
    J Antimicrob Chemother; 2012 Jan; 67(1):230-3. PubMed ID: 21972268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood concentrations of cefuroxime in cardiopulmonary bypass surgery.
    Bertholee D; ter Horst PG; Hijmering ML; Spanjersberg AJ; Hospes W; Wilffert B
    Int J Clin Pharm; 2013 Oct; 35(5):798-804. PubMed ID: 23794078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.
    Gertler R; Gruber M; Wiesner G; Grassin-Delyle S; Urien S; Tassani-Prell P; Martin K
    Br J Clin Pharmacol; 2018 Sep; 84(9):2020-2028. PubMed ID: 29761538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of cefuroxime in subcutaneous tissue during coronary artery bypass grafting surgery.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):3960-4. PubMed ID: 19853540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue and plasma concentrations of cephuroxime during cardiac surgery in cardiopulmonary bypass--a microdialysis study.
    Mand'ák J; Pojar M; Maláková J; Lonsk V; Palicka V; Zivný P
    Perfusion; 2007 Mar; 22(2):129-36. PubMed ID: 17708162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens.
    Asín-Prieto E; Soraluce A; Trocóniz IF; Campo Cimarras E; Sáenz de Ugarte Sobrón J; Rodríguez-Gascón A; Isla A
    Int J Antimicrob Agents; 2015 May; 45(5):504-11. PubMed ID: 25758019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations and pharmacokinetics of moxifloxacin in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.
    Wiesner G; Martin K; Gertler R; Braun SL; Tassani P; Lange R; Gruber M
    Int J Antimicrob Agents; 2013 May; 41(5):473-6. PubMed ID: 23481660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative cefuroxime pharmacokinetics in cardiac surgery.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    Clinics (Sao Paulo); 2007 Jun; 62(3):257-60. PubMed ID: 17589665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue and plasma concentrations of antibiotic during cardiac surgery with cardiopulmonary bypass--microdialysis study.
    Pojar M; Mandak J; Malakova J; Jokesova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):139-45. PubMed ID: 18795089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefuroxime plasma and tissue concentrations in patients undergoing elective cardiac surgery: Continuous vs bolus application. A pilot study.
    Skhirtladze-Dworschak K; Hutschala D; Reining G; Dittrich P; Bartunek A; Dworschak M; Tschernko EM
    Br J Clin Pharmacol; 2019 Apr; 85(4):818-826. PubMed ID: 30636060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saliva and blood concentration of cefuroxime in patients undergoing maxillofacial surgery.
    Venetis G; Chatzika K; Pitsiou G; Kechagias N; Antoniades K; Kioumis IP
    J Oral Maxillofac Surg; 2012 Jun; 70(6):1398-403. PubMed ID: 22459228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of post-cardiopulmonary bypass dosing of vancomycin in cardiac surgery.
    Raikhelkar JK; Reich DL; Schure R; Varghese R; Bodian C; Scurlock C
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):301-4. PubMed ID: 20841364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of antibiotic prophylaxis for primary total knee arthroplasty performed during ischemia.
    Soriano A; Bori G; García-Ramiro S; Martinez-Pastor JC; Miana T; Codina C; Maculé F; Basora M; Martínez JA; Riba J; Suso S; Mensa J
    Clin Infect Dis; 2008 Apr; 46(7):1009-14. PubMed ID: 18444817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.
    Barbour A; Schmidt S; Rout WR; Ben-David K; Burkhardt O; Derendorf H
    Int J Antimicrob Agents; 2009 Sep; 34(3):231-5. PubMed ID: 19411164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.